Update on Global Hemp Group
02 August 2023 Apollon Formularies Plc Update on Global Hemp Group Apollon Formularies plc (AQSE: APOL, "Apollon" or the "Company"), a UK based international pharmaceutical company trading on the AQSE Growth Market, that is licenced to research, develop, process, and sell medical cannabis therapeutic products that include legal medical cannabis to treat various illnesses under medical supervision, announces that the Company will not be proceeding with proposed deal with Global Hemp Group Inc. (“GHG”) under the binding letter of intent (“LOI”) released on the 12th of